Format

Send to

Choose Destination
See comment in PubMed Commons below
Breast Cancer Res. 2010;12(6):215. doi: 10.1186/bcr2781. Epub 2010 Dec 16.

Breast cancer metastasis to the bone: mechanisms of bone loss.

Author information

1
Department of Biochemistry and Molecular Cell Biology, The Pennsylvania State University, University Park, PA 16802, USA. yzc116@psu.edu

Abstract

Breast cancer frequently metastasizes to the skeleton, interrupting the normal bone remodeling process and causing bone degradation. Osteolytic lesions are the end result of osteoclast activity; however, osteoclast differentiation and activation are mediated by osteoblast production of RANKL (receptor activator for NFκB ligand) and several osteoclastogenic cytokines. Osteoblasts themselves are negatively affected by cancer cells as evidenced by an increase in apoptosis and a decrease in proteins required for new bone formation. Thus, bone loss is due to both increased activation of osteoclasts and suppression of osteoblasts. This review summarizes the current understanding of the osteolytic mechanisms of bone metastases, including a discussion of current therapies.

PMID:
21176175
PMCID:
PMC3046443
DOI:
10.1186/bcr2781
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center